FarmaKology’s Substack

FarmaKology-Mushroom Supplement Found to Slow Prostate Cancer

FarmaKology-Scientists created new antibody to combat breast cancer

FarmaKology-Eisai Commences Fully-Fledged Business Activities at Pharma Sales Subsidiary in South Africa

FarmaKology-Artificial Intelligence Speeds Up Parkinson’s Drug Development

FarmaKology-Gaza's elderly face war, displacement and medicine shortages

FarmaKology-Nanoform Collaborates with Takeda on Plasma-derived Therapy Development

FarmaKology-Incyte Partners with Qiagen to Create Diagnostic for Rare Blood Cancers

FarmaKology-Mendus receives U.S. FDA Fast Track Designation for vididencel in Acute Myeloid Leukemia

FarmaKology-New deep screening technique enables rapid discovery of high-affinity antibodies to clinically relevant drug targets

FarmaKology-Scientists Use AI to Discover Drugs That Kill “Zombie Cells” and Fight Age-Related Diseases

FarmaKology-Diabetes and Obesity Drugs May Reduce Risk of Dementia For Older Diabetes Patients

FarmaKology-Sandoz Biologics License Application for proposed biosimilar denosumab accepted by US FDA